Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Taylor, Jayne
DOB: 11-AUG-1946 (Age: 79)
Gender: female
ID: 8980-070719-5 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 19-JAN-2025

Problem list

Condition Onset Date Status
Alzheimer's disease 27-Dec-2020 active
Hyperlipidemia 19-Jul-1998 active
Ischemic heart disease 19-Jul-1992 active
Malignant neoplasm of breast 01-Jul-1987 active
Anemia 18-Apr-1976 active
Metabolic syndrome X 07-Apr-1974 active
Prediabetes 01-Apr-1973 active
Essential hypertension 01-Apr-1973 active
Sleep apnea 04-Feb-1973 active
Sleep disorder 10-Jan-1973 active

Medication list

No known medications

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 19-Jan-2025
Clostridium tetani toxoid antigen adsorbed only vaccine product 05-Feb-2023
SARS-CoV-2 mRNA vaccine 21-Feb-2021

Procedure History list

Procedure Date Reason
Sleep apnea assessment 12-Feb-2023 Sleep disorder (disorder)
Depression screening 05-Feb-2023 -
Medication reconciliation 05-Feb-2023 -
Assessment of health and social care needs 05-Feb-2023 -
Depression screening using Patient Health Questionnaire Two-Item score (procedure) 05-Feb-2023 -
Assessment of anxiety 07-Feb-2021 -
Assessment using Morse Fall Scale 07-Feb-2021 -
Pre-discharge assessment 04-Oct-2017 -
Discharge from skilled nursing facility (procedure) 04-Oct-2017 -
Professional / ancillary services care 03-Oct-2017 -
Nursing care/supplementary surveillance 03-Oct-2017 -
History AND physical examination 27-Sep-2017 -
Postoperative care 27-Sep-2017 Rupture of patellar tendon
Initial patient assessment 27-Sep-2017 -
Development of individualized plan of care 27-Sep-2017 -
Surgical manipulation of joint of knee 22-Sep-2017 Rupture of patellar tendon
Radiologic examination of knee 15-Sep-2017 -
Patient discharge 09-Feb-2017 -
Hospice care 08-Feb-2017 -
Notifications 22-Jan-2017 -
Certification procedure 22-Jan-2017 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Dementia management 27-Dec-2020 Alzheimer's disease (disorder)
  • Support maintenance or slow decline of cognitive abilities through dementia management interventions.
  • Minimize agitation, aggression, and other behavioral symptoms associated with Alzheimer's disease.
  • Ensure regular and appropriate use of prescribed Alzheimer's disease medications.
  • Enhance daily functioning and overall well-being through supportive dementia care.
  • Support independence in basic self-care activities for as long as possible.
Hyperlipidemia clinical management plan 09-Aug-1998 Hyperlipidemia
  • Achieve and maintain LDL cholesterol below 70 mg/dL to reduce cardiovascular risk.
  • Keep total cholesterol below 200 mg/dL.
  • Maintain HDL cholesterol above 50 mg/dL.
  • Keep triglycerides below 150 mg/dL.
Lifestyle education regarding hypertension 01-Apr-1973 Essential hypertension (disorder)
  • Patient will demonstrate understanding of hypertension and recommended lifestyle changes (diet, exercise, sodium reduction, medication adherence) within 3 months.
  • Maintain systolic blood pressure below 130 mm[Hg].
  • Maintain diastolic blood pressure below 80 mm[Hg].
Diabetes self management plan 01-Apr-1973 Prediabetes
  • Patient will participate in a diabetes self-management education program to improve understanding of prediabetes and implement lifestyle changes.
  • Maintain fasting plasma glucose within recommended range for prediabetes.
  • Maintain HbA1c below threshold for diabetes diagnosis.
  • Achieve and maintain at least 5% weight loss from baseline to reduce risk of progression to diabetes.
  • Engage in at least 150 minutes per week of moderate-intensity physical activity.
Care plan 04-Feb-1973 Sleep apnea (disorder)
  • Reduce the Apnea-Hypopnea Index (AHI) to less than 5 events per hour to improve sleep quality and reduce cardiovascular risk.
  • Achieve patient-reported improvement in sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI) score.
  • Reduce daytime sleepiness as measured by the Epworth Sleepiness Scale (ESS) to a score of less than 10.
Weight management program 07-Feb-1954 -
Immunization Recommendation Due Date Reason
Vaccine product containing only Influenza virus antigen (medicinal product) 01-Oct-2025 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-01-19 2024-01-14
Body Height 159.2 cm 159.2 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} 4 {score}
Body Weight 80.8 kg 80.8 kg
Body mass index (BMI) [Ratio] 31.9 kg/m2 31.9 kg/m2
Diastolic Blood Pressure 59 mm[Hg] 55 mm[Hg]
Systolic Blood Pressure 96 mm[Hg] 96 mm[Hg]
Heart rate 75 /min 98 /min
Respiratory rate 16 /min 14 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 19-JAN-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.0 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 94.5 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 11.9 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.5 L 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.1 8.5 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 137.5 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.7 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 103.3 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.0 L 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 151.4 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 109.7 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 72.0 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 57.5 50 - 100 mg/dL

Device Use

Device Date (since)
Appliance for sleep apnea (physical object) 05-Feb-2023
Blood glucose meter (physical object) 01-Apr-1973